<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16839</article-id><article-id pub-id-type="doi">10.25208/vdv16839</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>НАУЧНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Evaluation of the expression of <italic>FLG, AHR</italic> and <italic>ARNT</italic> genes in the skin of patients with atopic dermatitis after phototherapy</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка экспрессии генов <italic>FLG, AHR</italic> и <italic>ARNT</italic> в коже больных атопическим дерматитом после фототерапии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6328-363X</contrib-id><contrib-id contrib-id-type="spin">3574-4048</contrib-id><name-alternatives><name xml:lang="en"><surname>Kozlova</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Козлова</surname><given-names>Ирина Вячеславовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ikozlova_work@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9688-2727</contrib-id><contrib-id contrib-id-type="spin">3385-4723</contrib-id><name-alternatives><name xml:lang="en"><surname>Chikin</surname><given-names>Vadim V.</given-names></name><name xml:lang="ru"><surname>Чикин</surname><given-names>Вадим Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Senior Researcher</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, старший научный сотрудник</p></bio><email>chikin@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5989-7156</contrib-id><contrib-id contrib-id-type="spin">6103-0456</contrib-id><name-alternatives><name xml:lang="en"><surname>Gorodnichev</surname><given-names>Pavel V.</given-names></name><name xml:lang="ru"><surname>Городничев</surname><given-names>Павел Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>gorpav@icloud.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-9700-2455</contrib-id><contrib-id contrib-id-type="spin">4770-8904</contrib-id><name-alternatives><name xml:lang="en"><surname>Lagun</surname><given-names>Kseniya M.</given-names></name><name xml:lang="ru"><surname>Лагун</surname><given-names>Ксения Михайловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>xobanaa@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3967-8359</contrib-id><contrib-id contrib-id-type="spin">8806-8539</contrib-id><name-alternatives><name xml:lang="en"><surname>Nosov</surname><given-names>Nikita Y.</given-names></name><name xml:lang="ru"><surname>Носов</surname><given-names>Никита Юрьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.)</p></bio><bio xml:lang="ru"><p>кандидат биологических наук</p></bio><email>nnosov@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Research Center of Dermatovenereology and Cosmetology</institution></aff><aff><institution xml:lang="ru">Государственный научный центр дерматовенерологии и косметологии</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-01-27" publication-format="electronic"><day>27</day><month>01</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-02-07" publication-format="electronic"><day>07</day><month>02</month><year>2025</year></pub-date><volume>101</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>59</fpage><lpage>68</lpage><history><date date-type="received" iso-8601-date="2024-10-14"><day>14</day><month>10</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-01-19"><day>19</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Kozlova I.V., Chikin V.V., Gorodnichev P.V., Lagun K.M., Nosov N.Y.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Козлова И.В., Чикин В.В., Городничев П.В., Лагун К.М., Носов Н.Ю.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Kozlova I.V., Chikin V.V., Gorodnichev P.V., Lagun K.M., Nosov N.Y.</copyright-holder><copyright-holder xml:lang="ru">Козлова И.В., Чикин В.В., Городничев П.В., Лагун К.М., Носов Н.Ю.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/16839">https://vestnikdv.ru/jour/article/view/16839</self-uri><abstract xml:lang="en"><p><bold>Background</bold><bold>.</bold><italic> </italic>Ultraviolet irradiation of the skin can activate the cytoplasmic aryl hydrocarbon receptor AhR, which, in combination with its nuclear translocator ARNT binds to the promoter of the <italic>FLG</italic> gene encoding filaggrin, a protective skin barrier protein. This suggests that the therapeutic effect of phototherapy may be due not only to the immunosuppressive effect, but also to stimulation of filaggrin production.</p> <p><bold>Aims</bold><bold>.</bold><italic> </italic>To evaluate the effect of ultraviolet irradiation used for various phototherapy methods on the expression levels of the <italic>FLG</italic>, <italic>AHR</italic> and <italic>ARNT</italic> genes in the skin of patients with atopic dermatitis.</p> <p><bold>Methods</bold><bold>.</bold><italic> </italic>The expression levels of the <italic>FLG</italic>, <italic>AHR</italic> and <italic>ARNT</italic> genes were determined using real-time PCR. To define the severity of the disease, the SCORAD index was calculated.</p> <p><bold>Results</bold><bold>.</bold> 76 patients with atopic dermatitis were included in the study. 37 patients underwent narrow-band phototherapy; 39 — UFA1 therapy. Both methods of phototherapy were effective. After narrow-band phototherapy, the level of expression of the <italic>FLG</italic>, <italic>AHR</italic> and <italic>ARNT</italic> genes significantly increased. After UFA1 therapy, the expression of the <italic>AHR</italic> and <italic>ARNT</italic> genes increased, and no changes in the expression of the <italic>FLG</italic> gene were observed.</p> <p><bold>Conclusions</bold><bold>.<italic> </italic></bold>Data have been obtained indicating that the therapeutic effect of narrow-band phototherapy in atopic dermatitis may be due to stimulation of the expression of the <italic>FLG</italic> gene in the skin. The revealed changes in the expression of the <italic>AHR</italic> and <italic>ARNT</italic> genes indicate the possible involvement of their protein products AhR and ARNT in the pathogenesis of the disease.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование. </bold>Ультрафиолетовое облучение кожи может активировать цитоплазматический рецептор ароматических углеводородов AhR, который в комплексе со своим ядерным транслокатором ARNT связывается с промотором гена <italic>FLG</italic>, кодирующего белок защитного кожного барьера филаггрин. Это предполагает, что терапевтический эффект фототерапии может быть обусловлен не только иммуносупрессивным эффектом, но и стимуляцией продукции филаггрина.</p> <p><bold>Цель исследования.</bold> Оценить влияние ультрафиолетового облучения, используемого для различных методов фототерапии, на уровни экспрессии генов <italic>FLG</italic>, <italic>AHR </italic>и <italic>ARNT</italic> в коже пациентов с атопическим дерматитом.</p> <p><bold>Методы.</bold> В открытом проспективном сравнительном исследовании определяли уровни экспрессии генов <italic>FLG</italic>, <italic>AHR </italic>и<italic> ARNT</italic> в коже у больных с атопическим дерматитом, которым проводили узкополосную фототерапию или УФА1-терапию. Для определения степени тяжести заболевания рассчитывали индекс SCORAD. Экспрессию генов <italic>FLG</italic>, <italic>AHR </italic>и<italic> ARNT</italic> в коже исследовали методом полимеразной цепной реакции в реальном времени.</p> <p><bold>Результаты.</bold> В исследование было включено 76 больных атопическим дерматитом. В коже пациентов была значительно уменьшена экспрессия гена <italic>ARNT </italic>(<italic>p</italic> &lt; 0,05), отмечена тенденция к уменьшению экспрессии генов <italic>FLG </italic>и<italic> AHR</italic>. 37 больным была проведена узкополосная фототерапия,39 больным — УФА1-терапия. Эффективной была как узкополосная фототерапии, так и УФА1-терапия. После узкополосной фототерапии в коже значительно повысился уровень экспрессии генов <italic>FLG</italic>, <italic>AHR </italic>и<italic> ARNT.</italic> После УФА1-терапии увеличилась экспрессия генов <italic>AHR </italic>и<italic> ARNT</italic>, изменений экспрессии гена <italic>FLG</italic> не наблюдалось.</p> <p><bold>Заключение. </bold>Получены данные, свидетельствующие о том, что терапевтический эффект узкополосной фототерапии при атопическом дерматите может быть обусловлен стимуляцией экспрессии гена <italic>FLG</italic> в коже. Выявленные изменения экспрессии генов <italic>AHR</italic> и <italic>ARNT</italic> в коже больных атопическим дерматитом указывают на возможное участие их белковых продуктов AhR и ARNT в патогенезе заболевания.</p></trans-abstract><kwd-group xml:lang="en"><kwd>atopic dermatitis</kwd><kwd>narrow-band ultraviolet phototherapy</kwd><kwd>aryl hydrocarbon receptor</kwd><kwd>filaggrin</kwd><kwd>gene expression</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>атопический дерматит</kwd><kwd>узкополосная фототерапия</kwd><kwd>рецептор ароматических углеводородов</kwd><kwd>филаггрин</kwd><kwd>экспрессия генов</kwd></kwd-group><funding-group><funding-statement xml:lang="en">Ministry of Health of the Russian Federation as part of the implementation of the State task No. 056-00003-24-02 for 2024 and for the planning period of 2025 and 2026, approved on 03.07.2024.</funding-statement><funding-statement xml:lang="ru">Минздрав России в рамках выполнения Государственного задания № 056-00003-24-02 на 2024 г. и на плановый период 2025 и 2026 гг., утвержденного 07.03.2024.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Patrizi A, Raone B, Ravaioli GM. Management of atopic dermatitis: safety and efficacy of phototherapy. Clin Cosmet Investig Dermatol. 2015;8:511–520. doi: 10.2147/CCID.S87987</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ortiz-Salvador JM, Pérez-Ferriols A. Phototherapy in atopic dermatitis. Adv Exp Med Biol. 2017;996:279–286. doi: 10.1007/978-3-319-56017-5_23</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Кубанов А.А., Чикин В.В., Карамова А.Э., Давлетбаева Л.Х. Ультрафиолетовая терапия дальнего длинноволнового диапазона (УФА-1-терапия) в лечении больных атопическим дерматитом. Вестник дерматологии и венерологии. 2021;97(5):26–37. [Kubanov AA, Chikin VV, Karamova AE, Davletbaeva LK. Long-wavelength ultraviolet A (UVA-1) phototherapy for the treatment of patients with atopic dermatitis. Vestnik Dermatologii i Venerologii. 2021;97(5):26–37. (In Russ.)] doi: 10.25208/vdv1286</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Кубанов А.А., Чикин В.В., Карамова А.Э., Мончаковская Е.С. Узкополосная средневолновая ультрафиолетовая терапия больных атопическим дерматитом: эффективность и безопасность. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2022;99(6):79–88. [Kubanov AA, Chikin VV, Karamova AÉ, Monchakovskaya ES. Narrow-band medium-wave ultraviolet therapy in patients with atopic dermatitis: efficacy and safety. Problems of Balneology, Physiotherapy and Exercise Therapy. 2022;99(6):79-88. (In Russ.)] doi: 10.17116/kurort20229906179</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Чикин В.В., Карамова А.Э., Кубанов А.А., Жилова М.Б., Городничев П.В., Аулова К.М. Узкополосная средневолновая ультрафиолетовая терапия больных атопическим дерматитом: анализ факторов, влияющих на выраженность терапевтического эффекта. Вестник дерматологии и венерологии. 2023;99(5):52–63. [Chikin VV, Karamova AE, Kubanov AA, Zhilova MB, Gorodnichev PV, Aulova KM. Narrow-band UVB phototherapy in patients with atopic dermatitis: analysis of the factors determining treatment efficacy. Vestnik Dermatologii i Venerologii. 2023;99(5):52–63. (In Russ.)] doi: 10.25208/vdv15828</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Garritsen FM, Brouwer MW, Limpens J, Spuls PI. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. Br J Dermatol. 2014;170(3):501–513. doi: 10.1111/bjd.12645</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hart PH, Norval M, Byrne SN, Rhodes LE. Exposure to ultraviolet radiation in the modulation of human diseases. Annu Rev Pathol. 2019;14:55–81. doi: 10.1146/annurev-pathmechdis-012418-012809</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kemény L, Varga E, Novak Z. Advances in phototherapy for psoriasis and atopic dermatitis. Expert Rev Clin Immunol. 2019;15(11):1205–1214. doi: 10.1080/1744666X.2020.1672537</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Vieyra-Garcia PA, Wolf P. A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacol Ther. 2021;222:107784. doi: 10.1016/j.pharmthera.2020.107784</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Krutmann J, Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Investig Dermatol Symp Proc. 1999;4(1):70–72. doi: 10.1038/sj.jidsp.5640185</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Sethi G, Sodhi A. Role of p38 mitogen-activated protein kinase and caspases in UV-B-induced apoptosis of murine peritoneal macrophages. Photochem Photobiol. 2004;79(1):48–54.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Novák Z, Bérces A, Rontó G, Pállinger E, Dobozy A, Kemény L. Efficacy of different UV-emitting light sources in the induction of T-cell apoptosis. Photochem Photobiol. 2004;79(5):434–439. doi: 10.1562/ra-003r.1</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Tintle S, Shemer A, Suárez-Fariñas M, Fujita H, Gilleaudeau P, Sullivan-Whalen M, et al. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response. J Allergy Clin Immunol. 2011;128(3):583–93.e1-4. doi: 10.1016/j.jaci.2011.05.042</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Suárez-Fariñas M, Gittler JK, Shemer A, Cardinale I, Krueger JG, Guttman-Yassky E. Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB. J Allergy Clin Immunol. 2013;131(2):577–579. doi: 10.1016/j.jaci.2012.11.010</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Gambichler T, Kreuter A, Tomi NS, Othlinghaus N, Altmeyer P, Skrygan M. Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy. Br J Dermatol. 2008;158(5):1117–1120. doi: 10.1111/j.1365-2133.2008.08498.x</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol. 1999;140(6):995–1009. doi: 10.1046/j.1365-2133.1999.02898.x</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hatakeyama M, Fukunaga A, Washio K, Taguchi K, Oda Y, Ogura K, Nishigori C. Anti-inflammatory role of Langerhans cells and apoptotic keratinocytes in ultraviolet-B-induced cutaneous inflammation. J Immunol. 2017;199(8):2937–2947. doi: 10.4049/jimmunol.1601681</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Drislane C, Irvine AD. The role of filaggrin in atopic dermatitis and allergic disease. Ann Allergy Asthma Immunol. 2020;124(1):36–43. doi: 10.1016/j.anai.2019.10.008</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Fritsche E, Schäfer C, Calles C, Bernsmann T, Bernshausen T, Wurm M, et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci U S A. 2007;104(21):8851–8856. doi: 10.1073/pnas.0701764104</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Gargaro M, Scalisi G, Manni G, Mondanelli G, Grohmann U, Fallarino F. The landscape of AhR regulators and coregulators to fine-tune AhR functions. Int J Mol Sci. 2021;22(2):757. doi: 10.3390/ijms22020757</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Bock KW, Köhle C. The mammalian aryl hydrocarbon (Ah) receptor: from mediator of dioxin toxicity toward physiological functions in skin and liver. Biol Chem. 2009;390(12):1225–1235. doi: 10.1515/BC.2009.138</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Bock KW. Aryl hydrocarbon receptor (AHR): From selected human target genes and crosstalk with transcription factors to multiple AHR functions. Biochem Pharmacol. 2019;168:65–70. doi: 10.1016/j.bcp.2019.06.015</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Городничев П.В. Роль рецептора ароматических углеводородов в патогенезе атопического дерматита. Вестник дерматологии и венерологии. 2023;99(3):11–22. [Gorodnichev PV. The role of the aromatic hydrocarbon receptor in the pathogenesis of atopic dermatitis. Vestnik Dermatologii i Venerologii. 2023;99(3):11–22. (In Russ.)]. doi: https://doi.org/10.25208/vdv4775</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Tsuji G, Hashimoto-Hachiya A, Kiyomatsu-Oda M, Takemura M, Ohno F, Ito T, et al. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis. Cell Death Dis. 2017;8(7):e2931. doi: 10.1038/cddis.2017.322</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Furue M, Tsuji G, Mitoma C, Nakahara T, Chiba T, Morino-Koga S, et al. Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor. J Dermatol Sci. 2015;80(2):83–88. doi: 10.1016/j.jdermsci.2015.07.011</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. doi: 10.1111/jdv.14891</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Simonsen S, Thyssen JP, Heegaard S, et al. Expression of Filaggrin and its Degradation Products in Human Skin Following Erythemal Doses of Ultraviolet B Irradiation. Acta Derm Venereol. 2017;97(7):797–801. doi: https://doi.org/10.2340/00015555-2662</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Furue M, Hashimoto-Hachiya A, Tsuji G. Aryl hydrocarbon receptor in atopic dermatitis and psoriasis. Int J Mol Sci. 2019;20(21):5424. doi: 10.3390/ijms20215424</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Dec M, Arasiewicz H. Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review. Postepy Dermatol Alergol. 2024;41(1):9–19. doi: 10.5114/ada.2023.135617</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Shirley SN, Watson AE, Yusuf N. Pathogenesis of inflammation in skin disease: From molecular mechanisms to pathology. Int J Mol Sci. 2024;25(18):10152. doi: 10.3390/ijms251810152</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Napolitano M, Patruno C. Aryl hydrocarbon receptor (AhR) a possible target for the treatment of skin disease. Med Hypotheses. 2018;116:96–100. doi: 10.1016/j.mehy.2018.05.001</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120(1):150–155. doi: 10.1016/j.jaci.2007.04.031</mixed-citation></ref></ref-list></back></article>
